In this study, we aimed to elucidate the role of GP73 in regulating the EMT to promote the invasion and metastasis of bladder cancer through the TGF‐β1/Smad2 signalling pathway and to establish a theoretical foundation for the discovery of new molecular targets in the clinical treatment of bladder cancer. Here, SMAD2 is linked to urinary bladder cancer.